192 related articles for article (PubMed ID: 25931316)
1. Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study.
Mameli C; Pasinato A; Picca M; Bedogni G; Pisanelli S; Zuccotti GV;
Pharmacol Res; 2015 Jul; 97():79-83. PubMed ID: 25931316
[TBL] [Abstract][Full Text] [Related]
2. Pidotimod may prevent recurrent respiratory infections in children.
Licari A; De Amici M; Nigrisoli S; Marseglia A; Caimmi S; Artusio L; Marseglia GL
Minerva Pediatr; 2014 Oct; 66(5):363-7. PubMed ID: 25253184
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children.
Caramia G; Clemente E; Solli R; Mei V; Cera R; Carnelli V; Venturoli V; Corsini A
Arzneimittelforschung; 1994 Dec; 44(12A):1480-4. PubMed ID: 7857347
[TBL] [Abstract][Full Text] [Related]
4. Role of immunoactivation with pidotimod in recurrent respiratory infections in childhood.
Careddu P
Arzneimittelforschung; 1994 Dec; 44(12A):1506-11. PubMed ID: 7857353
[TBL] [Abstract][Full Text] [Related]
5. Pidotimod in the management of recurrent pharyngotonsillar infections in childhood.
Passali D; Calearo C; Conticello S
Arzneimittelforschung; 1994 Dec; 44(12A):1511-6. PubMed ID: 7857354
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of pidotimod in the prevention of recurrent respiratory infections in children: a multicentre study.
Namazova-Baranova LS; Alekseeva AA; Kharit SM; Kozhevnikova TN; Taranushenko TE; Tuzankina IA; Scarci F
Int J Immunopathol Pharmacol; 2014; 27(3):413-9. PubMed ID: 25280032
[TBL] [Abstract][Full Text] [Related]
7. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial.
Santamaria F; Montella S; Stocchero M; Pirillo P; Bozzetto S; Giordano G; Poeta M; Baraldi E
Pulm Pharmacol Ther; 2019 Oct; 58():101818. PubMed ID: 31302340
[TBL] [Abstract][Full Text] [Related]
8. Pidotimod, an immunostimulant in pediatric recurrent respiratory tract infections: A meta-analysis of randomized controlled trials.
Niu H; Wang R; Jia YT; Cai Y
Int Immunopharmacol; 2019 Feb; 67():35-45. PubMed ID: 30530167
[TBL] [Abstract][Full Text] [Related]
9. Immunoactivation by pidotimod in children with recurrent respiratory infections.
Burgio GR; Marseglia GL; Severi F; De Benedetti F; Masarone M; Ottolenghi A; Pagliano L; Serra U; Nespoli L
Arzneimittelforschung; 1994 Dec; 44(12A):1525-9. PubMed ID: 7857357
[TBL] [Abstract][Full Text] [Related]
10. Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial.
Jara-Pérez JV; Berber A
Clin Ther; 2000 Jun; 22(6):748-59. PubMed ID: 10929921
[TBL] [Abstract][Full Text] [Related]
11. Pidotimod: a reappraisal.
Riboldi P; Gerosa M; Meroni PL
Int J Immunopathol Pharmacol; 2009; 22(2):255-62. PubMed ID: 19505378
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation and changes of the respiratory epithelium function after administration of Pidotimod in Greek children with recurrent respiratory tract infections.
Aivazis V; Hatzimichail A; Papachristou A; Valeri R; Iuga-Donca G
Minerva Pediatr; 2002 Aug; 54(4):315-9. PubMed ID: 12131867
[TBL] [Abstract][Full Text] [Related]
13. Immunoactivity of pidotimod against episodes of recurrent tonsillitis in childhood.
Motta G; De Campora E; De Vita C; Esposito S; Galletti C; Incutti V; Mallardi V; Motta S; Pucci V; Salonna F
Arzneimittelforschung; 1994 Dec; 44(12A):1521-4. PubMed ID: 7857356
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulating activity of Pidotimod in children with Down syndrome.
Zuccotti GV; Mameli C; Trabattoni D; Beretta S; Biasin M; Guazzarotti L; Clerici M
J Biol Regul Homeost Agents; 2013; 27(1):253-8. PubMed ID: 23489705
[TBL] [Abstract][Full Text] [Related]
15. Pidotimod in the treatment of patients affected by bacterial exacerbations of chronic bronchitis.
Pozzi E; Dolcetti A; Orlandi O; Cirianni C; Moreo G; Piacenza G; Rampulla C; Fugazza L; Scarpazza G
Arzneimittelforschung; 1994 Dec; 44(12A):1495-8. PubMed ID: 7857350
[TBL] [Abstract][Full Text] [Related]
16. Pidotimod activity against chronic bronchitis exacerbations.
Ciaccia A
Arzneimittelforschung; 1994 Dec; 44(12A):1516-20. PubMed ID: 7857355
[TBL] [Abstract][Full Text] [Related]
17. Pidotimod: the past and the present.
Zuccotti GV; Mameli C
Ital J Pediatr; 2013 Dec; 39():75. PubMed ID: 24314100
[TBL] [Abstract][Full Text] [Related]
18. Effects of Pidotimod on recurrent respiratory infections in children with Down syndrome: a retrospective Italian study.
Valentini D; Di Camillo C; Mirante N; Marcellini V; Carsetti R; Villani A
Ital J Pediatr; 2020 Mar; 46(1):31. PubMed ID: 32164747
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of pidotimod in combination with bacterial lysates in the treatment of the pfapa (periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis) syndrome].
Buongiorno A; Pierossi N
Minerva Pediatr; 2015 Jun; 67(3):219-26. PubMed ID: 25941128
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome.
La Mantia I; Grillo C; Mattina T; Zaccone P; Xiang M; Di Mauro M; Meroni PL; Nicoletti F
J Chemother; 1999 Apr; 11(2):126-30. PubMed ID: 10326743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
